Skip to main content
Log in

Receptor-Ck regulates the expression of cyclin-dependent kinase inhibitors (p16; p27)

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The present study was addressed to understand the interrelationship between Receptor-Ck induction-activation coupling; isoprenoids (derived from mevalonate pathway) and cyclin-dependent kinase inhibitors. The results reported here unambiguously reveal that isoprenoids regulate the expression of genes coding for CDK inhibited p16 and p27. Further, Receptor-Ck dependent signalling, known to control the mevalonate pathway, had a direct effect upon the p27 gene expression. Based upon these studies coupled with our earlier findings we propose that Receptor-Ck has an important role in the regulation of cell cycle machinery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hirama T, Koeffler PH: Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841–854, 1995

    PubMed  Google Scholar 

  2. Bruce S: Cell cycle control of DNA replication. Science 274: 1659–1663, 1996

    PubMed  Google Scholar 

  3. Barbu V, Dautry F: Mevalonate deprivation alters the induction of fos and myc by growth factors. Oncogene 5: 1077–1080, 1990

    PubMed  Google Scholar 

  4. Siperstein MD: Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res 25: 1462–1468, 1994

    Google Scholar 

  5. Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA, Ewen ME: Ras signalling linked to the cell cycle machinery by the retinoblastoma protein. Nature 386: 177–181, 1997

    PubMed  Google Scholar 

  6. Linnete GP, Li Y, Roth K, Korsmeyer SJ: Cross talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 93: 9545–9552, 1996

    PubMed  Google Scholar 

  7. Kaul D, Varma N: Molecular mechanism involved in TPA-induced myelopoietic programming. Leukemia Res (in press)

  8. Kaur M, Kaul D, Sobti RC: Receptor-Ck dependent regulation of genes involved in the cell cycle. Mol Cell Biochem 181: 137–142, 1998

    PubMed  Google Scholar 

  9. Kaul D: Receptor-Ck and leukemogenesis. Leukemia Res 22: 389–394, 1998

    Google Scholar 

  10. Kaul D, Singh J: Does Receptor-Ck deficiency initiate leukemia? Cancer Lett 112: 199–202, 1997

    PubMed  Google Scholar 

  11. Kaul D, Kaur M: LDL-dependent regulation of Bcl-2 and cyclin ‘D’ gene expression in lymphocytes from normal and CML patients. Cancer Lett 119: 131–135, 1997

    PubMed  Google Scholar 

  12. Vitols S, Gahrton G, Ost A, Peterson C: Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation. Blood 63: 1186–1193, 1984

    PubMed  Google Scholar 

  13. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM: Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 93: 4350–4354, 1996

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaul, D., Kaur, M. Receptor-Ck regulates the expression of cyclin-dependent kinase inhibitors (p16; p27). Mol Cell Biochem 200, 183–186 (1999). https://doi.org/10.1023/A:1006981614054

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006981614054

Navigation